Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Stay within budget with practical, repeatable habits that reinforce good spending choices and support your financial goals.
22,060 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
Bitcoin is at a critical juncture, with traders eyeing a breakout above $68K to prevent further downside. This week’s...
As CPS Tech nears its Q4 2025 results, investors seek clarity on revenue, margins, and strategy. This guide breaks do...
A director sold 33,000 Clear Secure shares worth about $1.5 million, sparking questions about the stock's outlook. Th...
With $1,000 to invest, you’re at a crossroads: bet on XRP’s institutional plumbing or Zcash’s privacy-forward store o...
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
Bitcoin steadies above $60k as traders weigh a delicate recovery against stubborn resistance. The coming days will cl...
Oil's sudden jump rattled macro markets and prompted crypto traders to rethink bitcoin price prediction: just as BTC ...
Three ETFs with yields above 10% are drawing attention in March 2026, each using a different mechanism to pay out hig...
When a fintech stock investor trims a large stake in a rising Brazilian payments firm, traders and everyday investors...
Investing in AI stocks can be high reward but requires focus. This guide breaks down five top AI stocks to buy now, w...